Managers / Q3 2020 · view latest →
HC Advisors, LLC
CIK 0001803295 · 750 HAMMOND DRIVE, BDG 1, SUITE 200, SANDY SPRINGS, GA, 30328 · 4047054593
Reported Value
$124M
Q3 2020
Positions
76
Filings on Record
26
2019–present window
Filed
Nov 4, 2020
original filing
Summary
Hc Advisors, LLC reported $124M in U.S.-listed holdings across 76 positions for Q3 2020.
Its largest position, Schwab Intermediate Term, represents 17.7% of the portfolio.
Compared with Q2 2020, the fund opened 11 new positions and exited 14.
Portfolio Metrics
Turnover
+12.7%
vs prior filed quarter
Top-10 Concentration
+66.2%
share of reported value
Largest Position
+17.7%
Schwab Intermediate Term
New / Exited
11 / 14
positions this quarter
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- ETP · 85.8% · $106M
- Common Stock · 10.2% · $13M
- Closed-End Fund · 2.1% · $3M
- Other · 1.4% · $2M
- ADR · 0.5% · $645,000
Quarter-over-Quarter Changes full breakdown →
vs Q2 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| INVESCO EXCHANGE TRADED FD T | NEW | +2.8K | 2.8K | +$303,000 | $303,000 |
| ALXOALX ONCOLOGY HLDGS INC | NEW | +6.5K | 6.5K | +$245,000 | $245,000 |
| MTCHMATCH GROUP INC NEW | NEW | +2.2K | 2.2K | +$239,000 | $239,000 |
| BIOHAVEN PHARMACTL HLDG CO L | NEW | +3.4K | 3.4K | +$221,000 | $221,000 |
| BDTXBLACK DIAMOND THERAPEUTICS I | NEW | +6.7K | 6.7K | +$202,000 | $202,000 |
| LANDCADIA HLDGS II INC | NEW | +13.8K | 13.8K | +$199,000 | $199,000 |
| TCE2CELLDEX THERAPEUTICS INC NEW | NEW | +12.6K | 12.6K | +$187,000 | $187,000 |
| EQXEQUINOX GOLD CORP | NEW | +14.5K | 14.5K | +$170,000 | $170,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2020
48 positions
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | Schwab Intermediate Term | INTRM TRM TRES | 17.72% | $22M | 374.6K |
| 2 | Vanguard Total Stock Mkt | TOTAL STK MKT | 16.41% | $20M | 119.5K |
| 3 | iShares Treasury 7-10 Yr Bond | BARCLAYS 7 10 YR | 5.68% | $7M | 57.8K |
| 4 | FIRST TR MORNINGSTAR DIV LEA | SHS | 5.21% | $6M | 247.9K |
| 5 | Schwab US TIPS ETF | US TIPS ETF | 4.51% | $6M | 90.7K |
| 6 | iShares US Tech ETF | U.S. TECH ETF | 4.39% | $5M | 18.1K |
| 7 | Schwab Emg Mkt Equity ETF | EMRG MKTEQ ETF | 4.30% | $5M | 199.3K |
| 8 | IYFiShares US Financials ETFhistory → | U.S. FINLS ETF | 3.45% | $4M | 37.7K |
| 9 | Schwab US Lg-Cap Growth ETF | US LCAP GR ETF | 2.30% | $3M | 24.8K |
| 10 | Wisdom Tree Small Cap Div Fund ETF | COM | 2.26% | $3M | 133.2K |
| 11 | iShares US Healthcare ETF | US HLTHCARE ETF | 2.23% | $3M | 12.2K |
| 12 | Vanguard Russell | VNG RUS1000VAL · VNG RUS1000GRW | 2.22% | $3M | 19.7K |
| 13 | SCHWAB STRATEGIC TR | US DIVIDEND EQ | 2.02% | $3M | 45.4K |
| 14 | AAPLAPPLE INChistory → | COM | 2.01% | $2M | 21.5K |
| 15 | VDCVanguard Consumer Stapleshistory → | CONSUM STP ETF | 1.69% | $2M | 12.8K |
| 16 | iShares Global Comm Svcs | GBL COMM SVC ETF | 1.47% | $2M | 27.6K |
| 17 | Schwab US Agg Bond ETF | US AGGREGATE B | 1.44% | $2M | 31.9K |
| 18 | Schwab US Mid-Cap ETF | US MID-CAP ETF | 1.16% | $1M | 25.8K |
| 19 | Vanguard Intl Eqty Index | ALLWRLD EX US | 1.14% | $1M | 27.9K |
| 20 | Ishares Russell | RUSSELL 3000 ETF · RUS 1000 GRW ETF | 1.06% | $1M | 6.5K |
| 21 | Schwab US Small-Cap ETF | US SML CAP ETF | 1.01% | $1M | 18.3K |
| 22 | SPROTT PHYSICAL GOLD TRUST | UNIT | 0.80% | $986,000 | 65.5K |
| 23 | HDHome Depot Inc | COM | 0.73% | $906,000 | 3.3K |
| 24 | Schwab Int'l Equity ETF | INTL EQTY ETF | 0.70% | $871,000 | 27.7K |
| 25 | AMZNAMAZON COM INC | COM | 0.67% | $831,000 | 264 |
| 26 | VANGUARD S&P 500 ETF | S&P 500 ETF SHS | 0.63% | $784,000 | 2.5K |
| 27 | RETAEURREATA PHARMACEUTICALS INC | CL A | 0.60% | $738,000 | 7.6K |
| 28 | SPROTT PHYSICAL SILVER TR | TR UNIT | 0.59% | $727,000 | 87.9K |
| 29 | PAASPAN AMERICAN SILVER CORP | COM | 0.54% | $666,000 | 20.7K |
| 30 | Vanguard Small Cap Valu | SM CP VAL ETF | 0.54% | $665,000 | 6.0K |
| 31 | Vanguard MSCI EAFE Etf | FTSE DEV MKT ETF | 0.46% | $570,000 | 13.9K |
| 32 | NMI1EURKIRKLAND LAKE GOLD LTD | COM | 0.45% | $555,000 | 11.4K |
| 33 | SRPTSAREPTA THERAPEUTICS INC | COM | 0.43% | $529,000 | 3.8K |
| 34 | NRGXEURPIMCO ENRGY TACTICAL CR OPP | COM SHS BEN INT | 0.41% | $509,000 | 82.3K |
| 35 | AEMAGNICO EAGLE MINES F | COM | 0.39% | $483,000 | 6.1K |
| 36 | Vanguard Intermediate Term Corp Bonds | INT-TERM CORP | 0.38% | $474,000 | 4.9K |
| 37 | PFEPfizer Incorporated | COM | 0.36% | $445,000 | 12.1K |
| 38 | MSFTMicrosoft Corp | COM | 0.34% | $422,000 | 2.0K |
| 39 | ETNBGBP89BIO INC | COM | 0.34% | $420,000 | 16.4K |
| 40 | KOCoca Cola Company | COM | 0.34% | $418,000 | 8.5K |
| 41 | VNG RUS3000IDX | VANGUARD SCOTTSDALE FDS | 0.31% | $388,000 | 2.5K |
| 42 | Vanguard Russell 2000 Growth ETF | VNG RUS2000GRW | 0.31% | $387,000 | 2.4K |
| 43 | Vanguard Small Cap Grwth | SML CP GRW ETF | 0.29% | $365,000 | 1.7K |
| 44 | ASCENDIS PHARMA A S | SPONSORED ADR | 0.29% | $356,000 | 2.3K |
| 45 | PROSHARES TR | ULTRAPRO SHORT S | 0.27% | $339,000 | 39.0K |
| 46 | BNTXBIONTECH SE | SPONSORED ADS | 0.27% | $338,000 | 4.9K |
| 47 | CRISPR THERAPEUTICS AG | NAMEN AKT | 0.26% | $320,000 | 3.8K |
| 48 | INTCIntel Corp | COM | 0.26% | $318,000 | 6.1K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $149M | 60 | May 5, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $145M | 60 | Feb 11, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $142M | 61 | Nov 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $142M | 60 | Aug 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $134M | 62 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $125M | 59 | Feb 5, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $122M | 53 | Nov 5, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $108M | 50 | Aug 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $210M | 91 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $179M | 87 | Jan 25, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $168M | 83 | Nov 7, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $172M | 83 | Aug 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $162M | 81 | May 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $146M | 84 | Feb 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $145M | 85 | Nov 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $140M | 80 | Aug 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $158M | 83 | May 6, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $163M | 86 | Feb 2, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $152M | 81 | Oct 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $163M | 82 | Aug 9, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $155M | 89 | May 7, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $146M | 87 | Feb 8, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $124M | 76 | Nov 4, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $121M | 79 | Aug 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $23M | 29 | May 8, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $97M | 44 | Feb 13, 2020 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.